Brainstorm Cell Therapeutics, Inc. (BCLI)

0.936 -0.03 (-3.51%) USD  |  OTCM  |  Sep 28, 16:00
More

Brainstorm Cell Therapeutics Total Expenses (% of Quarterly Revenues)

Total Expenses (% of Quarterly Revenues) Chart

View Total Expenses (% of Quarterly Revenues) for BCLI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Quarterly Revenues) Chart
Start Trial

Historical Total Expenses (% of Quarterly Revenues) Data

View and export this data back to 2001. Start Trial.
Date Value
December 31, 2002 --
Date Value
September 30, 2001 --

Total Expenses (% of Quarterly Revenues) Range, Past 5 Years

View Total Expenses (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Quarterly Revenues) Benchmarks

View Total Expenses (% of Quarterly Revenues) Benchmarks
Start Trial
NovelStem International Corp. --
Summit Therapeutics, Inc. --
Kezar Life Sciences, Inc. --
Protara Therapeutics, Inc. --
Clene, Inc. Upgrade